"We strive to create products that enhance patient care," says Cain. "We understand that some may see this as a way for doctors to cut corners in favor of convenience. However, physicians have to answer for the decisions they make, and their choices are carefully considered. Before today, doctors who needed to see images but could not get to a workstation had to opt for a less preferable course of action or no action at all. When my health is in question, I don't want my care compromised because of the doctor's location."
Regarding the availability of Mobile MIM only on Apple devices, Cain said, "The iOS platform has proven itself with its combination of massive market penetration and a lineup of devices that are both tightly controlled in their manufacture and consistent in their characteristics. Without the steady consistency and quality of Apple products, we could not have sustained the scrutiny of the prolonged regulatory process."
Mobile MIM is intended for use by medical professionals, not patients. The company plans to release a second app intended for patients, VueMe™, in March. On July 5, 2010, MIM Software submitted a 513(g) request to the FDA to inquire about the classification of a patient image viewing iPhone app, and on September 3, 2010, the FDA determined that it would be a medical image storage device, a FDA class I medical device.
The Mobile MIM App is available for free from the U.S. App Store on the iPhone, iPod touch, and iPad, or at www.iTunes.com/AppStore.
About MIM Software Inc. (www.mimsoftware.com)
MIM Software Inc. provides practical imaging solutions in the fields of radiation oncology, radiology, nuclear medicine, neuroimaging, and cardiac imaging. MIM offers solutions
|SOURCE MIM Software Inc.|
Copyright©2010 PR Newswire.
All rights reserved